Cargando…
The human CD40 agonistic antibody ADC-1013 generates immune mediated anti-tumor effects in syngeneic tumor models in hCD40 transgenic mice
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4292546/ http://dx.doi.org/10.1186/2051-1426-2-S3-P251 |
| _version_ | 1782352498755895296 |
|---|---|
| author | Mangsbo, Sara M Veitonmäki, Niina Gustfson, Erika Smith, Karin Enell Furebring, Christina Norlén, Per Lindstedt, Malin Tötterman, Thomas H Ellmark, Peter |
| author_facet | Mangsbo, Sara M Veitonmäki, Niina Gustfson, Erika Smith, Karin Enell Furebring, Christina Norlén, Per Lindstedt, Malin Tötterman, Thomas H Ellmark, Peter |
| author_sort | Mangsbo, Sara M |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4292546 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2014 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-42925462015-01-15 The human CD40 agonistic antibody ADC-1013 generates immune mediated anti-tumor effects in syngeneic tumor models in hCD40 transgenic mice Mangsbo, Sara M Veitonmäki, Niina Gustfson, Erika Smith, Karin Enell Furebring, Christina Norlén, Per Lindstedt, Malin Tötterman, Thomas H Ellmark, Peter J Immunother Cancer Poster Presentation BioMed Central 2014-11-06 /pmc/articles/PMC4292546/ http://dx.doi.org/10.1186/2051-1426-2-S3-P251 Text en Copyright © 2014 Mangsbo et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Poster Presentation Mangsbo, Sara M Veitonmäki, Niina Gustfson, Erika Smith, Karin Enell Furebring, Christina Norlén, Per Lindstedt, Malin Tötterman, Thomas H Ellmark, Peter The human CD40 agonistic antibody ADC-1013 generates immune mediated anti-tumor effects in syngeneic tumor models in hCD40 transgenic mice |
| title | The human CD40 agonistic antibody ADC-1013 generates immune mediated anti-tumor effects in syngeneic tumor models in hCD40 transgenic mice |
| title_full | The human CD40 agonistic antibody ADC-1013 generates immune mediated anti-tumor effects in syngeneic tumor models in hCD40 transgenic mice |
| title_fullStr | The human CD40 agonistic antibody ADC-1013 generates immune mediated anti-tumor effects in syngeneic tumor models in hCD40 transgenic mice |
| title_full_unstemmed | The human CD40 agonistic antibody ADC-1013 generates immune mediated anti-tumor effects in syngeneic tumor models in hCD40 transgenic mice |
| title_short | The human CD40 agonistic antibody ADC-1013 generates immune mediated anti-tumor effects in syngeneic tumor models in hCD40 transgenic mice |
| title_sort | human cd40 agonistic antibody adc-1013 generates immune mediated anti-tumor effects in syngeneic tumor models in hcd40 transgenic mice |
| topic | Poster Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4292546/ http://dx.doi.org/10.1186/2051-1426-2-S3-P251 |
| work_keys_str_mv | AT mangsbosaram thehumancd40agonisticantibodyadc1013generatesimmunemediatedantitumoreffectsinsyngeneictumormodelsinhcd40transgenicmice AT veitonmakiniina thehumancd40agonisticantibodyadc1013generatesimmunemediatedantitumoreffectsinsyngeneictumormodelsinhcd40transgenicmice AT gustfsonerika thehumancd40agonisticantibodyadc1013generatesimmunemediatedantitumoreffectsinsyngeneictumormodelsinhcd40transgenicmice AT smithkarinenell thehumancd40agonisticantibodyadc1013generatesimmunemediatedantitumoreffectsinsyngeneictumormodelsinhcd40transgenicmice AT furebringchristina thehumancd40agonisticantibodyadc1013generatesimmunemediatedantitumoreffectsinsyngeneictumormodelsinhcd40transgenicmice AT norlenper thehumancd40agonisticantibodyadc1013generatesimmunemediatedantitumoreffectsinsyngeneictumormodelsinhcd40transgenicmice AT lindstedtmalin thehumancd40agonisticantibodyadc1013generatesimmunemediatedantitumoreffectsinsyngeneictumormodelsinhcd40transgenicmice AT tottermanthomash thehumancd40agonisticantibodyadc1013generatesimmunemediatedantitumoreffectsinsyngeneictumormodelsinhcd40transgenicmice AT ellmarkpeter thehumancd40agonisticantibodyadc1013generatesimmunemediatedantitumoreffectsinsyngeneictumormodelsinhcd40transgenicmice AT mangsbosaram humancd40agonisticantibodyadc1013generatesimmunemediatedantitumoreffectsinsyngeneictumormodelsinhcd40transgenicmice AT veitonmakiniina humancd40agonisticantibodyadc1013generatesimmunemediatedantitumoreffectsinsyngeneictumormodelsinhcd40transgenicmice AT gustfsonerika humancd40agonisticantibodyadc1013generatesimmunemediatedantitumoreffectsinsyngeneictumormodelsinhcd40transgenicmice AT smithkarinenell humancd40agonisticantibodyadc1013generatesimmunemediatedantitumoreffectsinsyngeneictumormodelsinhcd40transgenicmice AT furebringchristina humancd40agonisticantibodyadc1013generatesimmunemediatedantitumoreffectsinsyngeneictumormodelsinhcd40transgenicmice AT norlenper humancd40agonisticantibodyadc1013generatesimmunemediatedantitumoreffectsinsyngeneictumormodelsinhcd40transgenicmice AT lindstedtmalin humancd40agonisticantibodyadc1013generatesimmunemediatedantitumoreffectsinsyngeneictumormodelsinhcd40transgenicmice AT tottermanthomash humancd40agonisticantibodyadc1013generatesimmunemediatedantitumoreffectsinsyngeneictumormodelsinhcd40transgenicmice AT ellmarkpeter humancd40agonisticantibodyadc1013generatesimmunemediatedantitumoreffectsinsyngeneictumormodelsinhcd40transgenicmice |